Drug recall · August 26, 2026
Atropine Sulfate injection recall
Why: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967.
- Lots / codes
Lot #: 24353, Exp. Date: 9/30/2026.
- Quantity
- 89,775 vials
- Company
- American Regent, Inc., Shirley, NY
- Distribution
- Nationwide within the U.S
- Initiated
- July 24, 2026 · Voluntary: Firm initiated
- Classified
- August 26, 2026
- Reported
- August 26, 2026
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.